75
40. Eison, A. S., Eison, M. S., Torrente, J. R. et al.
Nefazodone: preclinical pharmacology of a new antidepressant.
Psychopharmacol. Bull. 26, 311-315. (1990)
41. Ewing, D. J. , Clarke, B. F.
Diagnosis and management of diabetic autonomic neuropathy.
Br. Med. J. 285, 916-918. (1982)
42. Ewing, D.J., Clarke, B.F.
Autonomie neuropathy: its diagnosis and prognosis.
J. Clin. Endocrinol. Metab. 15, 855-889. (1986)
43. Ferketich, A. K., Schwartzbaum, J. A., Frid, D. J., Moeschberger, M. L.
Depression as an antecedent to heart disease among women and men in the
NHANES I study. National Health and Nutrition Examination Survey.
Arch. Intern. Med. 8;160(9), 1261-8. (2000)
44. Fontaine, R., Ontiveros, A., Elie, R., Kensler, T. T., Roberts, D. L., Kaplita, S.,
Ecker, J. A., Faludi, G.
A double-blind comparison of nefazodone, imipramine, and placebo in major
depression.
J. Clin. Psychiatry. 55(6), 234-41. (1994)
45. Frasure-Smith, N., Lesperance, F., Talajic, M.
Depression following myocardial infarction: impact on 6-month survival.
JAMA. 270,1819-1825. (1993)
46. Goodwin, F. K., Jamison, K. R.
Manic-Depressive Illness.
New York: Oxford University Press. (1990)
47. Goodwin, F. K., Prange, A. J., Post, R. M., et al.
Potentiation of antidepressant effects by L-triiodothyronine in tricyclic non-
responders.
Am. J. Psychiatry. 139, 34-38. (1982)
48. Gorman, J. M., Sloan, R. P.
Depression as a risk factor for cardiovascular and cerebrovascular disease:
emerging data and clinical perspectives.
Am. Heart. J. 140, 77-83. (2000)
49. Greden, J. R., Gardner, R., King, D., et al.
Dexamethasone suppression tests in antidepressant treatment of melancholia.
Arch. Gen. Psychiatry. 40, 493-500. (1983)
50. Gries, F. A., Berger, H., Cicmir, I., Wiefels, K., Ziegler, D.
Diabetic polyneuropathies
Verh. Dtsch. Ges. Inn. Med. 93, 202-13. (1987)
|
